Content Block Tag: NRG-HN011: Recurrent or Metastatic Nasopharyngeal Cancer

‘Text/HTML’ of page ‘NRG-HN011: Recurrent or Metastatic Nasopharyngeal Cancer’

Am I eligible for this study? If you are over the age of 18 with nasopharyngeal carcinoma that has come back or spread outside of your nasopharynx, and you are not a candidate for surgery, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including […]

‘Text/HTML’ of page ‘NRG-HN011: Recurrent or Metastatic Nasopharyngeal Cancer’

About This Study NRG-HN011 is a clinical study for people with nasopharyngeal carcinoma that has come back or spread outside of your nasopharynx (metastatic) and who are not a candidate for surgery. This study will be testing whether a combination of the drugs nivolumab and BMS-986016 (relatlimab) after initial chemotherapy and immunotherapy will extend […]

‘Text/HTML’ of page ‘NRG-HN011: Recurrent or Metastatic Nasopharyngeal Cancer’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-HN011: Recurrent or Metastatic Nasopharyngeal Cancer’

The NRG-HN011 Study FAQ